Brazil

Brazil

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
7.9 (7 - 8.70) 1999 Survey/reported Silveira TR et al, 1999
0.54 (0.43 - 0.69) 2015 Modelled WHO
0.4 (0.20 - 0.60) 2016 Modelled Razavi-Shearer et al, 2018
0.65 (0.65 - 0.66) 2013 Modelled Schweitzer et al, 2015
0.52 2017 Modelled OPI: Hepatitis B Elimination in Brazil: Revisiting the Current Strategy
3.42 (2.97 - 3.84) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.77 (3.29 - 4.22) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.82 (3.32 - 4.28) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.83 (3.35 - 4.27) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.86 (3.38 - 4.28) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.92 (3.43 - 4.36) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4.05 (3.54 - 4.50) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.19 (3.66 - 4.68) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4.32 (3.77 - 4.84) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4.4 (3.83 - 4.94) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4.47 (3.89 - 5.01) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4.58 (3.98 - 5.12) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4.7 (4.10 - 5.26) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4.81 (4.21 - 5.39) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4.88 (4.26 - 5.48) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4.95 (4.31 - 5.55) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5.06 (4.40 - 5.66) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5.17 (4.51 - 5.80) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5.28 (4.60 - 5.95) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5.33 (4.64 - 6.03) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5.37 (4.67 - 6.06) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5.42 (4.71 - 6.12) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5.48 (4.76 - 6.18) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5.53 (4.78 - 6.22) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5.55 (4.79 - 6.25) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5.54 (4.79 - 6.24) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5.54 (4.78 - 6.23) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5.54 (4.79 - 6.24) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5.53 (4.79 - 6.23) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5.51 (4.78 - 6.24) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (3.19 - 4.11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.07 (0.05 - 0.11) 2015 Modelled WHO
0.12 (0.10 - 0.16) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.16 (0.13 - 0.21) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.17 (0.13 - 0.21) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.17 (0.13 - 0.21) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.13 - 0.21) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.13 - 0.20) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.13 - 0.21) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.17 (0.13 - 0.22) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.14 - 0.22) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.15 - 0.23) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.15 - 0.24) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.15 - 0.24) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.15 - 0.24) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.15 - 0.24) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.16 - 0.25) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.16 - 0.26) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.23 (0.18 - 0.29) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.24 - 0.38) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.31 - 0.50) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.41 - 0.65) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.51 - 0.82) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.74 - 1.17) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.41 (1.12 - 1.77) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.95 (1.54 - 2.43) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.4 (1.89 - 2.99) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.61 (2.07 - 3.27) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.66 (2.11 - 3.33) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.71 (2.15 - 3.39) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.74 (2.18 - 3.42) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.76 (2.20 - 3.45) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.75 (2.19 - 3.46) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.03) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
760,000 (415,000 - 1,249,000) 2016 Modelled Razavi-Shearer et al, 2018
7,404,410 (6,445,280 - 8,314,650) 2019 Modelled IHME, GBD 2019 (accessed 2020)
7,633,780 (6,660,560 - 8,561,950) 2019 Modelled IHME, GBD 2019 (accessed 2022)
7,799,310 (6,819,640 - 8,728,120) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7,832,090 (6,798,360 - 8,776,250) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7,765,550 (6,790,920 - 8,684,300) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7,727,490 (6,748,520 - 8,574,120) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7,780,630 (6,808,000 - 8,644,900) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7,944,460 (6,941,310 - 8,840,750) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8,144,180 (7,106,930 - 9,084,950) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8,308,040 (7,238,360 - 9,305,910) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8,366,940 (7,279,700 - 9,405,330) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8,402,050 (7,314,950 - 9,409,080) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8,505,620 (7,405,800 - 9,493,310) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8,626,840 (7,544,200 - 9,631,720) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8,716,310 (7,610,330 - 9,741,930) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8,725,770 (7,601,670 - 9,771,830) 2005 Modelled IHME, GBD 2019 (accessed 2022)
8,728,100 (7,604,760 - 9,774,610) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8,794,570 (7,673,410 - 9,840,490) 2003 Modelled IHME, GBD 2019 (accessed 2022)
8,875,480 (7,749,070 - 9,954,900) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8,922,530 (7,778,270 - 10,043,000) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8,888,360 (7,740,550 - 10,049,000) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8,817,520 (7,682,860 - 9,947,810) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8,770,530 (7,626,760 - 9,879,050) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8,724,740 (7,561,740 - 9,818,670) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8,658,640 (7,498,500 - 9,736,620) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8,550,720 (7,386,780 - 9,634,040) 1995 Modelled IHME, GBD 2019 (accessed 2022)
8,415,230 (7,270,090 - 9,478,970) 1994 Modelled IHME, GBD 2019 (accessed 2022)
8,279,960 (7,160,010 - 9,312,810) 1993 Modelled IHME, GBD 2019 (accessed 2022)
8,142,620 (7,024,720 - 9,170,150) 1992 Modelled IHME, GBD 2019 (accessed 2022)
8,001,690 (6,927,580 - 9,054,530) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7,856,960 (6,804,710 - 8,890,040) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

Number of new cases of HBV

National
Download
Value Year Type Source
6,064 2020 Survey/reported Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
0.2 2019 Survey/reported Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021
2.52 (2.24 - 2.83) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.9 (3.53 - 4.32) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.83 (3.46 - 4.25) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.83 (3.47 - 4.25) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.92 (3.54 - 4.33) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.91 (3.52 - 4.33) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.91 (3.54 - 4.35) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.88 (3.52 - 4.30) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.91 (3.52 - 4.33) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.92 (3.55 - 4.35) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.9 (3.53 - 4.32) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.93 (3.55 - 4.35) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.94 (3.55 - 4.37) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.94 (3.56 - 4.39) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.94 (3.56 - 4.37) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.95 (3.57 - 4.39) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.87 (3.51 - 4.31) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.76 (3.38 - 4.18) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.16 (2.85 - 3.53) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.5 (3.15 - 3.89) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.68 (2.41 - 3) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.57 - 3.18) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.63 (2.36 - 2.93) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (2.31 - 2.87) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.53 (2.26 - 2.83) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (2.24 - 2.78) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (2.20 - 2.76) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (2.22 - 2.78) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.44 (2.19 - 2.72) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.47 (2.22 - 2.78) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.52 (2.24 - 2.83) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
14,251 2016 Modelled WHO
368 2020 Survey/reported Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021
5,801 (5,253 - 6,424) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5,800 (5,235 - 6,436) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6,130 (5,545 - 6,768) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6,224 (5,627 - 6,923) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6,311 (5,692 - 6,999) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5,894 (5,336 - 6,542) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6,410 (5,777 - 7,104) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6,464 (5,857 - 7,162) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6,598 (5,971 - 7,312) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6,734 (6,094 - 7,470) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6,841 (6,185 - 7,577) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6,958 (6,301 - 7,765) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7,057 (6,354 - 7,837) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7,159 (6,474 - 7,936) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7,273 (6,581 - 8,076) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7,108 (6,387 - 7,896) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7,216 (6,546 - 8,035) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6,129 (5,521 - 6,829) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6,690 (6,021 - 7,446) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5,581 (5,034 - 6,233) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5,311 (4,771 - 5,948) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5,285 (4,731 - 5,887) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5,207 (4,680 - 5,816) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5,184 (4,640 - 5,800) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5,253 (4,682 - 5,867) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5,156 (4,600 - 5,765) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5,147 (4,631 - 5,751) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5,200 (4,659 - 5,803) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5,316 (4,769 - 5,967) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5,450 (4,858 - 6,140) 2019 Modelled IHME, GBD 2019 (accessed 2022)
5,450 (4,858 - 6,140) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
4 (3 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 5) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 5) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5 (5 - 6) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5 (5 - 6) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2019 Modelled IHME, GBD 2019 (accessed 2022)
17 (15 - 20) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
78 2019 Survey/reported WHO/UNICEF
80 2018 Survey/reported WHO/UNICEF
80 2017 Survey/reported WHO/UNICEF
82 2016 Survey/reported WHO/UNICEF
91 2015 Survey/reported WHO/UNICEF
88 2014 Survey/reported WHO/UNICEF
89 2013 Survey/reported WHO/UNICEF
90 2012 Survey/reported WHO/UNICEF
91 2011 Survey/reported WHO/UNICEF
92 2010 Survey/reported WHO/UNICEF
92 2009 Survey/reported WHO/UNICEF
93 2008 Survey/reported WHO/UNICEF
94 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
94 2005 Survey/reported WHO/UNICEF
92 2004 Survey/reported WHO/UNICEF
91 2003 Survey/reported WHO/UNICEF
93 2002 Survey/reported WHO/UNICEF
95 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
63 2020 Survey/reported WHO/UNICEF
62 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
80 2019 Survey/reported WHO/UNICEF
77 2020 Survey/reported WHO/UNICEF
68 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Partially Adopted
Castelo A et al
Routine official reports to monitor mortality
Adopted
OPI
System for monitoring testing and treatment
Adopted
Ministério da Saúde
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1998
Source: WHO
Eligible for HBV generic medicines
Source: MPP
Licensed point-of-care PCR testing to detect HBV
Adopted
OMS
No patient co-pays for HBsAg testing
Adopted
Ministério da Saúde
Recommendations for HBV testing of pregnant women
Adopted
Ministério da Saúde
HBV testing recommendations for key population (i.e. migrants, foreign-born, etc)
Adopted
Ministério da Saúde
National treatment guidelines exist
Adopted
Simplified care: No treatment co-pays
Adopted
Public budget line for testing and treatment
Adopted
Pan-American Health Organization and WHO
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
Routine official reports to monitor mortality
Adopted
OPI
System for monitoring testing and treatment
Adopted
Ministério da Saúde
Recommendations for HCV testing of pregnant women
Adopted
Ministério da Saúde
Registration of originator HCV DAAs
Adopted
OMS
Eligible for HCV generic medicines
Source: MPP
Registration of generic HCV DAAs
Adopted
OMS
Licensed point-of-care PCR testing to detect HCV
Adopted
OMS
HCV testing policy
Risk-based
Source:
HCV testing recommendations for key population (i.e. PWID)
Adopted
Ministério da Saúde
No patient co-pays for anti-HCV testing
Adopted
Ministério da Saúde
National treatment guidelines exist
Adopted
Ministério da Saúde
Simplified care: Non-specialists can prescribe treatment
Adopted
Governo do Brasil
Simplified care: No treatment co-pays
Adopted
Ministério da Saúde
No fibrosis restrictions
Adopted
Ministério da Saúde
No sobriety restrictions
Partially Adopted
Ministério da Saúde
National policy for harm reduction for persons who inject drugs
Adopted
Larney S et al
National policy for syringe exchange in federal prisons
Not Adopted
Larney S et al
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
OST in at least one prison
Source: Harm Reduction International
Decriminalization of possession of syringes and paraphernalia
Not Adopted
Larney S et al
Public budget line for testing and treatment
Adopted
Pan-American Health Organization and WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.9 (0.60 - 0.90) 2015 Modelled Blach et al, 2017
1.3 (0.10 - 1.30) 2014 Survey/reported Gower et al, 2014
0.53 2017 Modelled OPI: Hepatitis B Elimination in Brazil: Revisiting the Current Strategy
2.61 (2.11 - 3.23) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (2.08 - 3.19) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (2.06 - 3.18) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.63 (2.12 - 3.26) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.18 - 3.35) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.17 - 3.35) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.68 (2.16 - 3.33) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.66 (2.14 - 3.30) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.63 (2.12 - 3.27) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.6 (2.10 - 3.24) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (2.08 - 3.21) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (2.05 - 3.18) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.53 (2.03 - 3.16) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.51 (2.01 - 3.13) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.48 (1.98 - 3.10) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.93 - 3.01) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.31 (1.85 - 2.88) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.19 (1.75 - 2.73) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.09 (1.67 - 2.61) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (1.64 - 2.55) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.06 (1.65 - 2.56) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (1.68 - 2.62) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (1.73 - 2.69) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.21 (1.77 - 2.76) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.24 (1.78 - 2.80) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.24 (1.79 - 2.80) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.25 (1.79 - 2.81) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.25 (1.79 - 2.82) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.24 (1.79 - 2.82) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.24 (1.78 - 2.80) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (2.02 - 3.10) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.22 (0.16 - 0.24) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.38 (1.12 - 1.64) 2013 Survey/reported Pereira LMMB et al, 2014
1.38 2019 Modelled Jin et al. 2017
1.6 (1.10 - 1.60) 2014 Survey/reported Gower et al, 2014
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
7.3 (1.50 - 19.90) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
39.6 (24.90 - 56.40) 2019 Modelled Granados-Garcia V et al, 2019
63.9 (60.50 - 67.30) 2001 Survey/reported Caiaffa WT et al, 2006
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
1,787,000 (1,293,000 - 1,896,000) 2015 Modelled Blach et al, 2017
3,186,810 (2,539,570 - 4,000,900) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3,248,620 (2,587,920 - 4,075,340) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3,305,830 (2,631,310 - 4,143,470) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3,358,030 (2,674,060 - 4,204,840) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3,405,820 (2,712,360 - 4,261,130) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3,450,200 (2,748,220 - 4,319,530) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3,464,180 (2,765,000 - 4,327,760) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3,437,640 (2,746,410 - 4,286,310) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3,398,660 (2,717,920 - 4,235,190) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3,377,900 (2,704,200 - 4,207,640) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3,408,880 (2,731,570 - 4,243,820) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3,537,430 (2,834,590 - 4,403,330) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3,755,270 (3,004,520 - 4,674,330) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4,013,340 (3,209,850 - 5,001,350) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4,257,520 (3,409,410 - 5,311,680) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4,428,330 (3,553,270 - 5,526,740) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4,538,290 (3,639,280 - 5,653,860) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4,643,140 (3,726,050 - 5,780,080) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4,744,940 (3,816,570 - 5,907,340) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4,845,810 (3,907,100 - 6,031,290) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4,947,940 (3,986,790 - 6,157,680) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5,055,390 (4,075,970 - 6,269,580) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5,164,840 (4,159,810 - 6,408,130) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5,267,710 (4,241,050 - 6,532,550) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5,355,080 (4,319,710 - 6,634,970) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5,418,070 (4,382,510 - 6,727,720) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5,322,680 (4,297,860 - 6,611,920) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5,237,010 (4,212,760 - 6,507,980) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5,318,610 (4,294,040 - 6,602,360) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5,411,240 (4,369,350 - 6,710,360) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5,438,670 (4,395,940 - 6,741,050) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
128,000 (92,300 - 135,000) 2019 Modelled Dugan et al., 2021

Number of new cases of HCV

National
Download
Value Year Type Source
9,286 2020 Survey/reported Ministério da Saúde, Brasil. Indicadores e Dados Básicos das Hepatites nos Municípios Brasileiros

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
0.7 2019 Survey/reported Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021
4.59 (4.11 - 5.11) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.62 (3.27 - 3.98) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (3.22 - 3.91) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (3.22 - 3.91) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.63 (3.30 - 3.98) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.62 (3.28 - 3.99) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.62 (3.27 - 3.97) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.6 (3.26 - 3.95) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (3.23 - 3.91) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.57 (3.25 - 3.94) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.58 (3.25 - 3.95) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.58 (3.25 - 3.95) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.61 (3.27 - 3.99) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.64 (3.31 - 4.02) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.69 (3.34 - 4.08) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.74 (3.40 - 4.13) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.72 (3.37 - 4.10) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.79 (3.45 - 4.19) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4.08 (3.70 - 4.52) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.92 (3.57 - 4.32) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4.23 (3.85 - 4.67) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4.34 (3.93 - 4.81) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4.41 (3.99 - 4.89) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4.42 (4 - 4.90) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4.45 (4.03 - 4.92) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.47 (4.05 - 4.97) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4.44 (4.03 - 4.92) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4.54 (4.11 - 5.05) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4.46 (4.05 - 4.95) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4.59 (4.11 - 5.11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
4.52 (4.09 - 5.03) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
7,767 2016 Modelled WHO
1,405 2020 Survey/reported Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021
9,936 (8,915 - 11,066) 2019 Modelled IHME, GBD 2019 (accessed 2022)
9,936 (8,915 - 11,066) 2019 Modelled IHME, GBD 2019 (accessed 2020)
9,704 (8,787 - 10,805) 2018 Modelled IHME, GBD 2019 (accessed 2022)
9,506 (8,626 - 10,546) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9,585 (8,682 - 10,667) 2016 Modelled IHME, GBD 2019 (accessed 2022)
9,348 (8,481 - 10,402) 2015 Modelled IHME, GBD 2019 (accessed 2022)
9,204 (8,347 - 10,194) 2014 Modelled IHME, GBD 2019 (accessed 2022)
9,113 (8,271 - 10,083) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8,960 (8,117 - 9,930) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8,840 (8,011 - 9,803) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8,598 (7,800 - 9,535) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8,291 (7,543 - 9,162) 2009 Modelled IHME, GBD 2019 (accessed 2022)
7,902 (7,172 - 8,753) 2008 Modelled IHME, GBD 2019 (accessed 2022)
7,497 (6,827 - 8,263) 2007 Modelled IHME, GBD 2019 (accessed 2022)
7,166 (6,517 - 7,907) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6,930 (6,291 - 7,650) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6,884 (6,256 - 7,597) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6,695 (6,071 - 7,403) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6,530 (5,927 - 7,211) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6,382 (5,782 - 7,050) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6,244 (5,665 - 6,884) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6,152 (5,587 - 6,785) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6,044 (5,497 - 6,657) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5,928 (5,379 - 6,517) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5,899 (5,346 - 6,481) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5,840 (5,275 - 6,413) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5,761 (5,212 - 6,344) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5,683 (5,169 - 6,228) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5,474 (4,958 - 6,022) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5,385 (4,878 - 5,921) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5,382 (4,864 - 5,924) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
7 (6 - 8) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7 (7 - 8) 1992 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7 (7 - 8) 1993 Modelled IHME, GBD 2019 (accessed 2022)
7 (7 - 8) 1994 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 1998 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 10) 1999 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 10) 2000 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 10) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 11) 2002 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 12) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 11) 2003 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 13) 2006 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 14) 2008 Modelled IHME, GBD 2019 (accessed 2022)
12 (11 - 13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
13 (12 - 15) 2009 Modelled IHME, GBD 2019 (accessed 2022)
14 (12 - 15) 2010 Modelled IHME, GBD 2019 (accessed 2022)
14 (13 - 16) 2011 Modelled IHME, GBD 2019 (accessed 2022)
15 (13 - 17) 2012 Modelled IHME, GBD 2019 (accessed 2022)
15 (14 - 17) 2013 Modelled IHME, GBD 2019 (accessed 2022)
16 (14 - 17) 2014 Modelled IHME, GBD 2019 (accessed 2022)
16 (14 - 18) 2015 Modelled IHME, GBD 2019 (accessed 2022)
16 (15 - 18) 2016 Modelled IHME, GBD 2019 (accessed 2022)
17 (15 - 18) 2017 Modelled IHME, GBD 2019 (accessed 2022)
17 (15 - 19) 2018 Modelled IHME, GBD 2019 (accessed 2022)
17 (15 - 19) 2019 Modelled IHME, GBD 2019 (accessed 2022)
41 (37 - 45) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
16,966 2018 Survey/reported Ministério da Saúde: Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis
36,658 2019 Survey/reported Ministério da Saúde: Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis
19,219 2020 Survey/reported Ministério da Saúde: Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis
5,965 2021 Survey/reported Ministério da Saúde: Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis
Showing out of
Show more
Technical notes

Cumulative number of persons treated for HCV

National
Download
Value Year Type Source
7,459 2015 Survey/reported WHO, 2021
41,226 2016 Survey/reported WHO, 2021
78,666 2018 Survey/reported WHO, 2021
Showing out of
Show more

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016

Price of HCV cure (Average price in public sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
2,535.60 2019 Survey/reported WHO, 2021

Price of HCV cure (Cheapest price in public sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
705 2019 Survey/reported WHO, 2021
HBV National Action Plan
HBV elimination goal
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Partially Adopted
Castelo A et al
Routine official reports to monitor mortality
Adopted
OPI
System for monitoring testing and treatment
Adopted
Ministério da Saúde
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1998
Source: WHO
Eligible for HBV generic medicines
Source: MPP
Licensed point-of-care PCR testing to detect HBV
Adopted
OMS
No patient co-pays for HBsAg testing
Adopted
Ministério da Saúde
Recommendations for HBV testing of pregnant women
Adopted
Ministério da Saúde
HBV testing recommendations for key population (i.e. migrants, foreign-born, etc)
Adopted
Ministério da Saúde
National treatment guidelines exist
Adopted
Simplified care: No treatment co-pays
Adopted
Public budget line for testing and treatment
Adopted
Pan-American Health Organization and WHO
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
Routine official reports to monitor mortality
Adopted
OPI
System for monitoring testing and treatment
Adopted
Ministério da Saúde
Recommendations for HCV testing of pregnant women
Adopted
Ministério da Saúde
Registration of originator HCV DAAs
Adopted
OMS
Eligible for HCV generic medicines
Source: MPP
Registration of generic HCV DAAs
Adopted
OMS
Licensed point-of-care PCR testing to detect HCV
Adopted
OMS
HCV testing policy
Risk-based
Source:
HCV testing recommendations for key population (i.e. PWID)
Adopted
Ministério da Saúde
No patient co-pays for anti-HCV testing
Adopted
Ministério da Saúde
National treatment guidelines exist
Adopted
Ministério da Saúde
Simplified care: Non-specialists can prescribe treatment
Adopted
Governo do Brasil
Simplified care: No treatment co-pays
Adopted
Ministério da Saúde
No fibrosis restrictions
Adopted
Ministério da Saúde
No sobriety restrictions
Partially Adopted
Ministério da Saúde
National policy for harm reduction for persons who inject drugs
Adopted
Larney S et al
National policy for syringe exchange in federal prisons
Not Adopted
Larney S et al
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
OST in at least one prison
Source: Harm Reduction International
Decriminalization of possession of syringes and paraphernalia
Not Adopted
Larney S et al
Public budget line for testing and treatment
Adopted
Pan-American Health Organization and WHO

Overview

HBV elimination goal
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
3.66 (%)
2019
(3.19 - 4.11(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
2.61 (%)
2019
(2.11 - 3.23(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

HBV (HBsAg+)
7.9 (%)
1999
(7 - 8.7(%))
Silveira TR et al, 1999
HCV (anti-HCV)
1.6 (%)
2014
(1.1 - 1.6(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
5,450
2019
(4,858 - 6,140)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

HBV
368
2020
Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021
HBV chart

Modelled

HCV
9,936
2019
(8,915 - 11,066)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

HCV
1,405
2020
Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021
HCV chart

Prevalence < 5

HBV
0.03 (%)
2020, latest modelled
(0.02 - 0.03(%))
WHO

Prevalence PWID

HCV
39.60 (%)
2019, latest modelled
(24.90 - 56.40(%))
Granados-Garcia V et al, 2019

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
62 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Download National Hepatitis Elimination Profile (N-HEP)

Latest news

View all

Action plan

View all

Elimination champion

News

Action plans

Resources

Programs

Partners